share_log

Psychedelic Stock Gainers And Losers From February 1, 2023

Psychedelic Stock Gainers And Losers From February 1, 2023

自 2023 年 2 月 1 日起 Psychedelic 股票的涨跌幅
Benzinga Real-time News ·  2023/02/01 16:32

GAINERS:

赢家:

  • Cybin (AMEX:CYBN) shares closed up 11.01% at $0.43
  • ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.37% at $1.84
  • Numinus Wellness (OTC:NUMIF) shares closed up 2.35% at $0.20
  • GH Research (NASDAQ:GHRS) shares closed up 2.25% at $9.09
  • Compass Pathways (NASDAQ:CMPS) shares closed up 2.22% at $10.61
  • Cybin (AMEX: CYBN)股价收盘上涨11.01%,至0.43美元
  • ATAI 生命科学 纳斯达克股票代码:ATAI)股价收盘上涨3.37%,至1.84美元
  • 努米努斯健康 (场外交易代码:NUMIF)股价收盘上涨2.35%,至0.20美元
  • 生长激素研究 纳斯达克股票代码:GHRS)股价收盘上涨2.25%,至9.09美元
  • 罗盘之路 纳斯达克股票代码:CMPS)股价收盘上涨2.22%,至10.61美元

LOSERS:

失败者:

  • Seelos Therapeutics (NASDAQ:SEEL) shares closed down 0.14% at $0.81
  • Mind Medicine (NASDAQ:MNMD) shares closed down 0.88% at $3.44
  • Seelos Therap 纳斯达克股票代码:SEEL)股价收盘下跌0.14%,至0.81美元
  • 心灵医学 纳斯达克股票代码:MNMD)股价收盘下跌0.88%,至3.44美元

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发